Sharon Benzeno

Chief Commercial Ofc Imm Med

Sharon Benzeno (Chief Commercial Ofc Imm Med) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $10.1M of ADPT (606,402 sh across 2 lots, as filed), executed Nov 20 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$14.7M

shares × price, as filed

Last traded

Jun 29

Filed Jun 30

Median ADV $72.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $15.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

ADPT

Adaptive Biotechnologies Corporation ADPT · 0 buys · 5 sells 5 filings

Recent filings

ADPTSALE Adaptive Biotechnologies Corporation View filing → $3.5M
165,802 sh across 2 lots
Exec Jun 26
Filed Jun 30 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $831K
63,103 sh × $13.17
Exec Mar 11
Filed Mar 13 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $212K
12,604 sh × $16.85
Exec Dec 4 2025
Filed Dec 8 2025 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $10.1M
606,402 sh across 2 lots
Exec Nov 20 2025
Filed Nov 24 2025 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation View filing → $290K
41,600 sh × $6.98
Exec Mar 5 2025
Filed Mar 6 2025 · 5:30 PM ET